ALMS (STOCKS)
Alumis Inc. Common Stock
$23.882000
-1.668000 (-6.53%)
Prev close: $25.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Martin Babler
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,109.53M
- Employees
- 252
- P/E (TTM)
- -12.70
- P/B (TTM)
- 5.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $8.40M |
| Benefits Costs and Expenses | $254.38M |
| Costs And Expenses | $254.38M |
| Nonoperating Income/Loss | $204.71M |
| Operating Expenses | $459.09M |
| Depreciation and Amortization | $3.60M |
| Research and Development | $370.92M |
| Other Operating Expenses | $84.57M |
| Operating Income/Loss | -$450.69M |
| Income/Loss From Continuing Operations After Tax | -$237.42M |
| Income/Loss From Continuing Operations Before Tax | -$237.42M |
| Net Income/Loss | -$237.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$237.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$237.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.78 |
| Diluted Earnings Per Share | -$1.78 |
| Basic Average Shares | 155,800,005 |
| Diluted Average Shares | 155,800,005 |
| Assets | $671.59M |
| Current Assets | $532.41M |
| Cash | $569.50M |
| Noncurrent Assets | $139.18M |
| Fixed Assets | $17.53M |
| Other Non-current Assets | $121.65M |
| Liabilities | $104.57M |
| Current Liabilities | $70.90M |
| Accounts Payable | $11.59M |
| Wages | $5.53M |
| Other Current Liabilities | $53.79M |
| Noncurrent Liabilities | $33.66M |
| Equity | $567.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $567.02M |
| Liabilities And Equity | $671.59M |
| Net Cash Flow From Operating Activities | -$376.25M |
| Net Cash Flow From Operating Activities, Continuing | -$376.25M |
| Net Cash Flow From Investing Activities | -$37.24M |
| Net Cash Flow From Investing Activities, Continuing | -$37.24M |
| Net Cash Flow From Financing Activities | $308.13M |
| Net Cash Flow From Financing Activities, Continuing | $308.13M |
| Net Cash Flow | -$105.36M |
| Net Cash Flow, Continuing | -$105.36M |
| Comprehensive Income/Loss | -$237.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$237.90M |
| Other Comprehensive Income/Loss | -$111.24M |
| Other Comprehensive Income/Loss Attributable To Parent | -$459.00K |